Cargando…

Weighted gene coexpression network analysis identifies a new biomarker of CENPF for prediction disease prognosis and progression in nonmuscle invasive bladder cancer

BACKGROUND: The dreadful prognosis of nonmuscle invasive bladder cancer mainly results from the delay in recognition of individuals with a high risk of progression. Thus, the emphasis of this work lies in developing valuable biomarkers that is conducive to accurately predicting the progression of NM...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shi, Jiawei, Zhang, Pu, Liu, Lilong, Min, Xiaobo, Xiao, Yajun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6825849/ https://www.ncbi.nlm.nih.gov/pubmed/31566930 http://dx.doi.org/10.1002/mgg3.982

Ejemplares similares

Overexpression of CENPF is associated with progression and poor prognosis of lung adenocarcinoma
por: Li, Mei-Xiang, et al.
Publicado: (2021)

Advances in nonmuscle invasive bladder cancer
por: Konety, Badrinath R.
Publicado: (2015)

Diagnostics techniques in nonmuscle invasive bladder cancer
por: Soubra, Ayman, et al.
Publicado: (2015)

Intravesical immunotherapy in nonmuscle invasive bladder cancer
por: Jokisch, Jan-Friedrich, et al.
Publicado: (2015)

Active surveillance for nonmuscle invasive bladder cancer
por: Miyake, Makito, et al.
Publicado: (2016)

CD73 Predicts Favorable Prognosis in Patients with Nonmuscle-Invasive Urothelial Bladder Cancer
por: Wettstein, Marian S., et al.
Publicado: (2015)

Nonmuscle invasive bladder cancer: a primer on immunotherapy
por: Maruf, Mahir, et al.
Publicado: (2016)

New therapies in nonmuscle invasive bladder cancer treatment
por: Rayn, Kareem N., et al.
Publicado: (2018)

Emerging intravesical therapies for management of nonmuscle invasive bladder cancer
por: Tomaszewski, Jeffrey J, et al.
Publicado: (2010)

New and contemporary markers of prognosis in nonmuscle invasive urothelial cancer
por: Ather, M Hammad, et al.
Publicado: (2015)

Weighted gene coexpression network analysis reveals hub genes involved in cholangiocarcinoma progression and prognosis
por: Tian, Aiping, et al.
Publicado: (2019)

Role of CCNB1, CENPF, and neutrophils in lung cancer diagnosis and prognosis
por: Tan, Feixiang, et al.
Publicado: (2023)

The Role of Interferon in the Management of BCG Refractory Nonmuscle Invasive Bladder Cancer
por: Correa, Andres F., et al.
Publicado: (2015)

Optimal Treatment for Intermediate- and High-Risk, Nonmuscle-Invasive Bladder Cancer
por: van der Meijden, A.P.M.
Publicado: (2006)

Minimal required PDT light dosimetry for nonmuscle invasive bladder cancer
por: Lilge, Lothar, et al.
Publicado: (2020)

Metabolomics analysis reveals distinct profiles of nonmuscle‐invasive and muscle‐invasive bladder cancer
por: Sahu, Divya, et al.
Publicado: (2017)

Overexpression of CENPF correlates with poor prognosis and tumor bone metastasis in breast cancer
por: Sun, Jingbo, et al.
Publicado: (2019)

Predictive Markers for the Recurrence of Nonmuscle Invasive Bladder Cancer Treated with Intravesical Therapy
por: Miyata, Yasuyoshi, et al.
Publicado: (2015)

Minimal required PDT light dosimetry for nonmuscle invasive bladder cancer (Erratum)
por: Lilge, Lothar, et al.
Publicado: (2020)

The use of blue-light cystoscopy in the detection and surveillance of nonmuscle invasive bladder cancer
por: Cahill, Ellen M., et al.
Publicado: (2022)

The indispensable role of urinalysis for patients undergoing treatment for nonmuscle invasive bladder cancer
por: Di Gianfrancesco, Luca, et al.
Publicado: (2022)

Identification of hub miRNA biomarkers for bladder cancer by weighted gene coexpression network analysis
por: Zhao, Feng, et al.
Publicado: (2017)

CENPF promotes papillary thyroid cancer progression by mediating cell proliferation and apoptosis
por: Han, Yong, et al.
Publicado: (2021)

Upregulation of CENPF is linked to aggressive features of osteosarcoma
por: Zou, Ping-An, et al.
Publicado: (2021)

Deciphering the Prognostic and Therapeutic Significance of Cell Cycle Regulator CENPF: A Potential Biomarker of Prognosis and Immune Microenvironment for Patients with Liposarcoma
por: Chen, Jiahao, et al.
Publicado: (2023)

Efficacy of pirarubicin for nonmuscle invasive bladder cancer: A protocol of systematic review and meta-analysis
por: Chen, Da-Yin, et al.
Publicado: (2020)

Molecular changes during progression from nonmuscle invasive to advanced urothelial carcinoma
por: Sjödahl, Gottfrid, et al.
Publicado: (2019)

Erectile dysfunction in nonmuscle-invasive bladder cancer patients before and after transurethral resection (TUR) of bladder tumor in China
por: Guo, Peng, et al.
Publicado: (2021)

CENPF promotes the proliferation of renal cell carcinoma in vitro
por: Zhang, Ji, et al.
Publicado: (2023)

[Retracted] Upregulation of CENPF is linked to aggressive features of osteosarcoma
por: Zou, Ping-An, et al.
Publicado: (2023)

Gene coexpression network analysis identified potential biomarkers in gestational diabetes mellitus progression
por: Zhao, Xiaomin, et al.
Publicado: (2018)

Identifying Tumorigenesis and Prognosis-Related Genes of Lung Adenocarcinoma: Based on Weighted Gene Coexpression Network Analysis
por: Yi, Ming, et al.
Publicado: (2020)

CENPF as an independent prognostic and metastasis biomarker corresponding to CD4+ memory T cells in cutaneous melanoma
por: Li, Mengzhi, et al.
Publicado: (2022)

FOXM1 and CENPF are associated with a poor prognosis through promoting proliferation and migration in lung adenocarcinoma
por: Li, Peipei, et al.
Publicado: (2023)

Clinical Significance of Substaging and HER2 Expression in Papillary Nonmuscle Invasive Urothelial Cancers of the Urinary Bladder
por: Lim, So Dug, et al.
Publicado: (2015)

MicroRNA-21 could be a molecular marker to predict the recurrence of nonmuscle invasive bladder cancer
por: Mitash, Nilay, et al.
Publicado: (2017)

A retrospective analysis of patients treated with intravesical BCG for high-risk nonmuscle invasive bladder cancer
por: Joshua, Julie Mariam, et al.
Publicado: (2019)

Predicting recurrence of nonmuscle-invasive bladder cancer (Ta-T1): A study based on 477 patients
por: Lu, Mengxin, et al.
Publicado: (2019)

Assessment of Pain Management, Acceptance of Illness, and Adjustment to Life with Cancer in Patients with Nonmuscle Invasive Bladder Cancer
por: Krajewski, Wojciech, et al.
Publicado: (2018)

A Urinary Drug-Disposing Approach as an Alternative to Intravesical Chemotherapy for Treating Nonmuscle Invasive Bladder Cancer
por: Bellat, Vanessa, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4rhdboejvfrti3vnsn8hu47bmc